InvestorPlace - Stock Market News, Stock Advice & Trading Tips
While the FDA may have some questions regarding Veru’s Covid-19 therapeutic, investors remain optimistic about VERU stock.
The post VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug appeared first on InvestorPlace.
More From InvestorPlace